Revive Therapeutics Ltd C.RVV

Alternate Symbol(s): RVVTF

Healthcare

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).

CSE:RVV - Post by User

Revive Therapeutics Ltd > Trial update: Push back to June 30.

<< Previous

Bullboard Posts

Next >>

Comment by TheTerminator1on Apr 22, 2022 2:46pm

119 Views

Post# 34624732

RE:RE:RE:Trial update: Push back to June 30.

Coming from a a guy who don't always call them right!!!

Trippedstocks wrote:
if that's how your read PR's, sure, anytime.... in December of 2020 MF said EUA would be anytime. You've been all in since then?

there will not be an ad hoc meeting. They are waiting for the "scheduled" 800 interim analysis.... Which we still only have 715 of. But turkey will be starting anytime now, right? Should only be a week to get 85 patients, right?

but it's super bullish that we will be done this quarter.... MF said we would... Or was that Q1? Q4-2021? Anytime now you say? I don't think they have missed a target milestone yet right?

Bucillamine works against covid.... But MF doesn't